USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Therapeutic Monoclonal Antibodies Markets
U.S. Therapeutic Monoclonal Antibodies Markets
RELEASE DATE
25-May-2005
25-May-2005
REGION
North America
North America
Research Code: F337-01-00-00-00
SKU: HC01446-NA-MR_05925
$2,450.00
In stock
SKU
HC01446-NA-MR_05925
Description
The U.S. Therapeutic Monoclonal Antibodies Markets is a evolving market undergoing many changes. This research service includes in depth analysis of the total market as well as the various therapeutic classes for which monoclonal antibodies are available. This analysis includes revenue forecasts, product/pipeline analysis, and strategic perspectives of the market. A number of strategic recommendations to be successful are provided in the research service.
Table of Contents
Executive Summary
- Executive Summary
Objectives and Scope
- Objectives
- Scope
Monoclonal Antibodies Market Overview
- Introduction
- Structure of Antibodies
- Typical Problems with Murine mAbs
- The Role of Hybridoma Clone
- Medical Utility of mAbs
- Market Overview
Evolution and Technology Trends
- Introduction
- Early Murine mAbs
- Chimeric mAbs
- Humanized mAbs
- Fully Human mAbs
- Phage Display of Human mAbs
- Monoclonal Antibodies as Carriers
- Naked Monoclonal Antibodies
- Conjugated Monoclonal Antibodies
Future of Monoclonal Antibodies
- The Foundation for Optimistic Future
- Return on Investment and Future
Challenges Affecting the US Therapeutic Monoclonal Antibodies Market
Overview of the mAbs Pipeline
Market Dynamics
Market Forecasts
Frost and Sullivan Awards
- Introduction
- Market Engineering Measurement
- Market Drivers
- Market Restraints
Competitive Structure
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Strategic Recommendations
Oncology Databases
Autoimmune and Inflammatory Disorders Databases
Organ Transplant Databases
Cardiovascular Databases
Popular Topics
The U.S. Therapeutic Monoclonal Antibodies Markets is a evolving market undergoing many changes. This research service includes in depth analysis of the total market as well as the various therapeutic classes for which monoclonal antibodies are available. This analysis includes revenue forecasts, product/pipeline analysis, and strategic perspectives of the market. A number of strategic recommendations to be successful are provided in the research service.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F337-01-00-00-00 |
| Is Prebook | No |